Cargando…

Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum

The most advanced P. falciparum circumsporozoite protein-based malaria vaccine, RTS,S/AS01 (RTS,S), confers partial protection but with antibody titers that wane relatively rapidly, highlighting the need to elicit more potent and durable antibody responses. Here, we elucidate crystal structures, bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pholcharee, Tossapol, Oyen, David, Flores-Garcia, Yevel, Gonzalez-Paez, Gonzalo, Han, Zhen, Williams, Katherine L., Volkmuth, Wayne, Emerling, Daniel, Locke, Emily, Richter King, C., Zavala, Fidel, Wilson, Ian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887213/
https://www.ncbi.nlm.nih.gov/pubmed/33594061
http://dx.doi.org/10.1038/s41467-021-21221-4
_version_ 1783651931707670528
author Pholcharee, Tossapol
Oyen, David
Flores-Garcia, Yevel
Gonzalez-Paez, Gonzalo
Han, Zhen
Williams, Katherine L.
Volkmuth, Wayne
Emerling, Daniel
Locke, Emily
Richter King, C.
Zavala, Fidel
Wilson, Ian A.
author_facet Pholcharee, Tossapol
Oyen, David
Flores-Garcia, Yevel
Gonzalez-Paez, Gonzalo
Han, Zhen
Williams, Katherine L.
Volkmuth, Wayne
Emerling, Daniel
Locke, Emily
Richter King, C.
Zavala, Fidel
Wilson, Ian A.
author_sort Pholcharee, Tossapol
collection PubMed
description The most advanced P. falciparum circumsporozoite protein-based malaria vaccine, RTS,S/AS01 (RTS,S), confers partial protection but with antibody titers that wane relatively rapidly, highlighting the need to elicit more potent and durable antibody responses. Here, we elucidate crystal structures, binding affinities and kinetics, and in vivo protection of eight anti-NANP antibodies derived from an RTS,S phase 2a trial and encoded by three different heavy-chain germline genes. The structures reinforce the importance of homotypic Fab-Fab interactions in protective antibodies and the overwhelmingly dominant preference for a germline-encoded aromatic residue for recognition of the NANP motif. In this study, antibody apparent affinity correlates best with protection in an in vivo mouse model, with the more potent antibodies also recognizing epitopes with repeating secondary structural motifs of type I β- and Asn pseudo 3(10) turns; such insights can be incorporated into design of more effective immunogens and antibodies for passive immunization.
format Online
Article
Text
id pubmed-7887213
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78872132021-03-03 Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum Pholcharee, Tossapol Oyen, David Flores-Garcia, Yevel Gonzalez-Paez, Gonzalo Han, Zhen Williams, Katherine L. Volkmuth, Wayne Emerling, Daniel Locke, Emily Richter King, C. Zavala, Fidel Wilson, Ian A. Nat Commun Article The most advanced P. falciparum circumsporozoite protein-based malaria vaccine, RTS,S/AS01 (RTS,S), confers partial protection but with antibody titers that wane relatively rapidly, highlighting the need to elicit more potent and durable antibody responses. Here, we elucidate crystal structures, binding affinities and kinetics, and in vivo protection of eight anti-NANP antibodies derived from an RTS,S phase 2a trial and encoded by three different heavy-chain germline genes. The structures reinforce the importance of homotypic Fab-Fab interactions in protective antibodies and the overwhelmingly dominant preference for a germline-encoded aromatic residue for recognition of the NANP motif. In this study, antibody apparent affinity correlates best with protection in an in vivo mouse model, with the more potent antibodies also recognizing epitopes with repeating secondary structural motifs of type I β- and Asn pseudo 3(10) turns; such insights can be incorporated into design of more effective immunogens and antibodies for passive immunization. Nature Publishing Group UK 2021-02-16 /pmc/articles/PMC7887213/ /pubmed/33594061 http://dx.doi.org/10.1038/s41467-021-21221-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Pholcharee, Tossapol
Oyen, David
Flores-Garcia, Yevel
Gonzalez-Paez, Gonzalo
Han, Zhen
Williams, Katherine L.
Volkmuth, Wayne
Emerling, Daniel
Locke, Emily
Richter King, C.
Zavala, Fidel
Wilson, Ian A.
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
title Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
title_full Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
title_fullStr Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
title_full_unstemmed Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
title_short Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
title_sort structural and biophysical correlation of anti-nanp antibodies with in vivo protection against p. falciparum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887213/
https://www.ncbi.nlm.nih.gov/pubmed/33594061
http://dx.doi.org/10.1038/s41467-021-21221-4
work_keys_str_mv AT pholchareetossapol structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT oyendavid structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT floresgarciayevel structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT gonzalezpaezgonzalo structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT hanzhen structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT williamskatherinel structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT volkmuthwayne structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT emerlingdaniel structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT lockeemily structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT richterkingc structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT zavalafidel structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum
AT wilsoniana structuralandbiophysicalcorrelationofantinanpantibodieswithinvivoprotectionagainstpfalciparum